Antidepressants Influence Somatostatin Levels and Receptor Pharmacology in Brain (original) (raw)

• Artigas F, Adell A, Celada P (2006). Pindolol augmentation of antidepressant response. Current Drug Targets 7: 139–147.
  Article CAS PubMed Google Scholar
• Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083–1152.
  Article CAS PubMed Google Scholar
• Berton O, Nestler EJ (2006). New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7: 137–151.
  Article CAS PubMed Google Scholar
• Bissette G (2001). Effects on regional neuropeptide concentrations in olfactory bulbectomized rats. Pharmacol Biochem Behav 69: 269–281.
  Article CAS PubMed Google Scholar
• Bissette G, Klime V, Pan J, Stockmeier C, Ordway G (2003). Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28: 1328–1335.
  Article CAS PubMed Google Scholar
• Bissette G, Widerlov E, Walleus H, Karlsson I, Eklund K, Forsman A et al (1986). Alterations in cerebrospinal fluid concentrations of somatostatin like immunoreactivity in neuropsychiatric disorders. Arch Gen Psych 43: 1148–1151.
  Article CAS Google Scholar
• Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 72: 248–254.
  Article CAS PubMed Google Scholar
• Brownstein MJ, Arimura A, Sato H, Schally AV, Kizer JS (1975). The regional distribution of somatostatin in the rat brain. Endocrinology 96: 1456–1461.
  Article CAS PubMed Google Scholar
• Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G (2001). Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21: RC141(1–4).
  Article Google Scholar
• Charlton B, Leake A, Wright C, Fairbairan AF, McKeith IG, Candy JM et al (1988). Somatostatin content and receptors in cerebral cortex of depressed and control subjects. J Neurol Neurosurg Psychiatry 51: 719–721.
  Article CAS PubMed PubMed Central Google Scholar
• Charney DS, Menkes DB, Heninger GR (1981). Receptor sensitivity and the mechanisms of action of antidepressant treatment: implications for the etiology and therapy of depression. Arch Gen Psychiatry 38: 1160–1180.
  Article CAS PubMed Google Scholar
• Chihara K, Arimura A, Schally AV (1979). Effects of intraventricular injection of dopamine, norepinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology 104: 1656–1661.
  Article CAS PubMed Google Scholar
• Daws C, Toney GM, Gerhardt GA, Frazer A (1998). In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther 286: 967–976.
  CAS PubMed Google Scholar
• Dournaud P, Boudin H, Schonbrunn A, Tannenbaum GS, Beaudet A (1998). Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci 18: 1056–1071.
  Article CAS PubMed PubMed Central Google Scholar
• Epelbaum J, Blue-Pajot MT, Llorens-Cortes C, Kordon C, Mounier F, Senut MC et al (1990). 125I-[Tyro, D-Trp8]somatostatin-14 binding sites in the locus coeruleus of the rat are located on both ascending and descending projecting noradrenergic cells. Peptides 11: 21–27.
  Article CAS PubMed Google Scholar
• Fehlmann D, Langenegger D, Schuepbach E, Siehler S, Feuerbach D, Hoyer D (2000). Distribution and characterization of somatostatin receptor mRNA and binding sites in the brain and periphery. J Physiol Paris 94: 265–281.
  Article CAS PubMed Google Scholar
• Gerner RH, Yamada T (1982). Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res 238: 298–302.
  Article CAS PubMed Google Scholar
• Gheorvassaki EG, Thermos K, Liapakis G, Spyraki C (1992). Effects of acute and chronic desipramine treatment on somatostatin receptors in brain. Psychopharmacology 108: 363–366.
  Article CAS PubMed Google Scholar
• Hathway GJ, Humphrey PP, Kendrick KM (1999). Evidence that somatostatin sst2 receptors mediate striatal dopamine release. Br J Pharmacol 128: 1346–1352.
  Article CAS PubMed PubMed Central Google Scholar
• Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humprey PP et al (1995). Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16: 86–88.
  Article CAS PubMed Google Scholar
• Kakigi T, Maeda K (1992). Effect of serotonergic agents on regional concentration of somatostatin and neuropeptide Y-like immunoreactivities in rat brain. Brain Res 599: 42–50.
  Article Google Scholar
• Kakigi T, Maeda K, Kaneda H, Chihara K (1992). Repeated administration of antidepressant drugs reduces regional somatostatin concentration in rat brain. J Affect Dis 25: 215–220.
  Article CAS PubMed Google Scholar
• Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ et al (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640–1645.
  Article CAS PubMed Google Scholar
• Kreienkamp H-J, Roth A, Richter D (1998). Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331). DNA Coll Biol 17: 869–878.
  Article CAS Google Scholar
• Lopez-Sanudo S, Arilla E (1992). Desmethylimipramine pretreatment prevents 6-hydroxydopamine induced somatostatin receptor reduction in the rat hippocampus. Regul Pept 41: 227–236.
  Article CAS PubMed Google Scholar
• Luttgen M, OveOgren S, Meister B (2004). Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res 1010: 156–165.
  Article CAS PubMed Google Scholar
• Mikkelsen JD, Woldbye DPD (2006). Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J Psych Res 40: 153–159.
  Article Google Scholar
• Munoz-Acedo G, Lopez-Sanudo S, Arilla E (1992). Reduction of somatostatin receptors in rat hippocampus by treatment with 5,7-dihydroxytryptamine. Neurosci Lett 146: 60–64.
  Article CAS PubMed Google Scholar
• Nouel D, Gaudriault G, Goule M, Reisine T, Vincent J-P, Mazella J et al (1997). Differential internalization of somatostatin in COS-7 cells transfected with sst1 and sst2 receptor subtype: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology 138: 296–306.
  Article CAS PubMed Google Scholar
• Palkovits M, Brownstein MJ (1988). Maps and Guides to Microdissection of the Rat Brain. Elsevier: New York.
  Google Scholar
• Pallis E, Spyraki C, Thermos K (2006). Chronic antidepressant treatment modulates the release of somatostatin in the rat nucleus accumbens. Neurosci Lett 395: 76–81.
  Article CAS PubMed Google Scholar
• Pallis E, Thermos K, Spyraki C (2001). Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens. Eur J Neurosci 14: 763–767.
  Article CAS PubMed Google Scholar
• Palvimaki EP, Majasuo H, Syvalahti E, Hietala J (2005). Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroidplexus after fluoxetine and citalopram treatments. Pharmacol Res 51: 419–425.
  Article PubMed Google Scholar
• Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn, Academic Press Inc: San Diego.
  Google Scholar
• Pazzaglia PJ, George MS, Post RM, Rubinow DR, Davis CL (1995). Nimodipine increases somatostatin in affective ill patients. Neuropsychopharmacology 13: 75–83.
  Article CAS PubMed Google Scholar
• Prosperini E, Rizzi M, Fumagalli F, Tarizzo G, Samanin R, Bendotti C (1997). Acute and chronic treatments with citalopram lower somatostatin levels in rat brain striatum through different mechanisms. J Neurochem 69: 206–213.
  Article CAS PubMed Google Scholar
• Raynor K, Lucki I, Reisine T (1993). Somatostatin-1 receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity. J Pharmacol Exp Ther 265: 67–73.
  CAS PubMed Google Scholar
• Richardson SB, Hollander CS, Prasad JA, Hirooka Y (1981). Somatostatin release from rat hypothalamus in vitro: effects of melatonin and serotonin. Endocrinology 109: 602–606.
  Article CAS PubMed Google Scholar
• Roosterman D, Kreuzer OJ, Brune N, Cottrell GS, Bunnett NW, Meyerhof W et al (2007). Agonist-induced endocytosis of rat somatostatin receptor 1. Endocrinology 148: 1050–1058.
  Article CAS PubMed Google Scholar
• Rubinow DR (1986). Cerebrospinal fluid somatostatin and psychiatric illness. Biol Psychiatry 21: 341–365.
  Article CAS PubMed Google Scholar
• Rubinow DR, Gold PW, Post R, Ballenger JC, Cowdry R, Bollinger J et al (1983). CSF somatostatin in affective illness. Arch Gen Psych 40: 409–412.
  Article CAS Google Scholar
• Schindler M, Kidd EJ, Carruthers AM, Jarvie EM, Sellers LA, Feniuk W et al (1998). Molecular cloning and functional characterization of a rat somatostatin sst2(B) receptor splice variant. Br J Pharmacol 25: 209–217.
  Article Google Scholar
• Schulz S, Handel M, Schreff M, Schmidt H, Hollt V (2000). Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Phys Paris 94: 259–264.
  Article CAS Google Scholar
• Siehler S, Seuwen K, Hoyer D (1999). Characterisation of human recombinant somatostatin receptors: 1 radioligand binding studies. Nauyn Schmied Arch Pharmacol 360: 488–499.
  Article CAS Google Scholar
• Skolnick P, Legutko B, Li X, Bymaster FP (2001). Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 43: 411–443.
  Article CAS PubMed Google Scholar
• Stahl SM (1998). Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Dis 51: 215–235.
  Article CAS PubMed Google Scholar
• Stroh T, Jackson AC, Dal Farra C, Schonbrunn A, Vincent JP, Beaudet A (2000). Receptor-mediated internalization of somatostatin in rat cortical and hippocampal neurons. Synapse 38: 177–186.
  Article CAS PubMed Google Scholar
• Thermos K, Bagnoli P, Epelbaum J, Hoyer D (2006). The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina? Pharmacol Ther 110: 455–464.
  Article CAS PubMed Google Scholar
• Thermos K, Radke J, Kastellakis A, Anagnostakis Y, Spyraki C (1996). Dopamine–somatostatin interactions in the rat striatum: an in vivo microdialysis study. Synapse 22: 209–216.
  Article CAS PubMed Google Scholar
• Thoss VS, Perez J, Duc D, Hoyer D (1995). Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34: 1673–1688.
  Article CAS PubMed Google Scholar
• Vasilaki A, Papasava D, Hoyer D, Thermos K (2004). The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat. Neuropharmacology 47: 612–618.
  Article CAS PubMed Google Scholar
• Videau C, Hochgeschwender U, Kreienkamp HJ, Brennan MB, Viollet C, Richter D et al (2003). Characterization of [125I]-Tyr0D-Trp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain. Nauyn Schmied Arch Pharmacol 367: 562–571.
  Article CAS Google Scholar
• Vincent SR, Johansson O (1983). Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J Comp Neurol 217: 264–270.
  Article CAS PubMed Google Scholar
• Wong M, Licinio J (2004). From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3: 136–151.
  Article CAS PubMed Google Scholar
• Zobel AW, Nicke T, Kunze HE, Ackl N, Sonntag A, Ising M et al (2000). Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiat Res 34: 171–181.
  Article CAS PubMed Google Scholar